Molecular Partners Ag (MOLN) Cash & Equivalents (2020 - 2025)
Molecular Partners Ag (MOLN) has disclosed Cash & Equivalents for 2 consecutive years, with $72.9 million as the latest value for Q4 2024.
- On a quarterly basis, Cash & Equivalents changed N/A to $72.9 million in Q4 2024 year-over-year; TTM through Dec 2024 was $72.9 million, a N/A change, with the full-year FY2024 number at $72.6 million, changed N/A from a year prior.
- Cash & Equivalents was $72.9 million for Q4 2024 at Molecular Partners Ag, down from $91.3 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $91.3 million in Q4 2022 to a low of $72.9 million in Q4 2024.